Global Electrocardiographs Market - GLOBAL:2021

Market Report Coverage :
Start Year : 2021 - Forecast Year : 2031 - Start Value : $4,646.3 Million in 2021 - Forecast Value : $9,826.8 Million by 2031 - CAGR % : 0.08%
Description :
Market Report Coverage - ElectrocardiographsMarket Segmentation• Product Type – Conventional Devices (Resting ECG Devices, Stress ECG Devices), Emerging Devices (Implantable Loop Recorders, Mobile Cardiac Telemetry, Holter Monitors, Cardiac Event Monitors)• End Users – Hospitals and Clinics, Home Care Settings and Ambulatory Surgical Centers and Others• Region – North America, Europe, Asia-Pacific, Latin America, and Middle East and AfricaRegional Segmentation• North America – U.S. and Canada• Europe – Germany, U.K., France, Italy, Spain, Russia, Nordic Countries, Benelux Countries, and Rest-of-Europe• Asia-Pacific- China, Japan, South Korea, India, Australia and New Zealand, and Rest-of-Asia-Pacific• Latin America- Brazil, Mexico, Argentina, Colombia, Rest-of-Latin-America• Middle East and Africa- K.S.A, South Africa, U.A.E, Rest-of-Middle East-and-AfricaMarket Growth Drivers• Increasing Prevalence of Cardiovascular Diseases (CVDs) and other Heart-Related Diseases• Growing Demand for Point-of-Care Diagnostic Systems• Rising End-User Preference for Non-Invasive Diagnostic Technologies over Invasive TechnologiesMarket Challenges• Longer Turnaround Time (TAT)• Incomplete and False DiagnosisMarket Opportunities• Growing Market Preference for Multimodal Diagnostic Imaging Systems• Implementation of ECG in Hybrid Operating RoomsKey Companies ProfiledAbbott Laboratories, Biotricity, Inc., BIOTRONIK SE & Co. KG, Boston Scientific Corporation, CardioComm Solutions, Inc., Cardioline SpA, Fukuda Denshi Co., Ltd., General Electric Company, Hill-Rom Holdings, Inc., iRhythm Technologies, Inc., Koninklijke Philips N.V., Medtronic plc, Nihon Kohden Corporation, OSI Systems, Inc., Zoll Medical Corporation (Asahi Kasei Corporation)How This Report Can Add ValueWho should buy this report?• Electrocardiographs manufacturers (emerging and established) • Established technology companies • Cardiac instruments and Cath lab manufacturers • Healthcare facilitiesKey questions answered in the Report• What was the impact of the COVID-19 pandemic on the global electrocardiographs market?• What are the key technological trends that influence the global electrocardiographs market? What is their future potential?• Who are the emerging or regional players in the global electrocardiographs market?• What are the legal regulations for electrocardiograph devices across various economies?• How has the patent filing trend influenced the growth of the global electrocardiographs market?• Who are the key players in the global electrocardiographs market?• What are the key synergistic activities employed by the companies operating or entering the global electrocardiographs market?• What are the key drivers and restraints for the global electrocardiographs market? • What are the growth opportunities in the global electrocardiographs market? • Which product type is anticipated to grow with the highest CAGR during the forecast period 2021-2031? • Which geographical region is anticipated to dominate the global electrocardiographs market during the forecast period 2021-2031?Global Electrocardiographs OverviewAn electrocardiograph (ECG) machine records the electrical activity of your heart. The ECG machine detects the electrical signals that make the heart pump blood around body. Conventional devices and emerging devices are two types of electrocardiographs based on product type. Conventional devices can be categorized into resting ECG machines and stress ECG machines. Electrocardiographs are currently dominated by conventional devices. ECG monitoring systems have been created and widely used in the healthcare business for past decades, and as smart supporting technologies have emerged, they have evolved substantially. ECG monitoring devices are now often employed in hospitals, home care settings, outpatient ambulatory settings, and remote settings. Under conventional devices segment, resting ECG machines and stress ECG machines are included, whereas, under the emerging devices segment, implantable loop recorders, mobile cardiac telemetry, Holter monitors, and cardiac event monitors are included in the report.The global electrocardiographs market report highlights that the market was valued at $4,394.1 million in 2020 and is expected to reach $9,826.8 million by the end of 2031. The market is expected to grow at a CAGR of 7.8% during the forecast period 2021-2031.Global Electrocardiographs Market DynamicsIn the global electrocardiographs market, advancements have already occurred and are currently conquering the industry. There is significant potential for these developing and new technologies to promote the total growth of the market with the advent of advanced technologies that can be easily used in ambulatory and home care settings.Some of the ongoing diseases are cardiovascular diseases, ischemic heart disease, strokes, hypertensive heart disease, congenital heart disease, rheumatic heart disease, cardiomyopathy, myocarditis, and aortic aneurysms. Many ailments are largely avoidable, treatable, and manageable with early detection and treatment. In addition, chronic illnesses are the leading cause of disability and death in the world. The prevalence of cardiovascular and related diseases propels market growth. The point-of-care (POC) market is growing exponentially, as POC devices assist in promptly ruling out suspected cardiac, vascular, and other disorders. Also, rising end-user preference for non-invasive diagnostic technologies over invasive technologies drives the market.Accuracy, precision, timeliness, and authenticity are the four foundations of good laboratory services. In order to improve the analytical difficulties of sample processing, clinical biochemists typically overlook the need for timeliness. Clinicians, on the other hand, usually use timeliness as a benchmark for laboratory performance, which is expressed as the turnaround time (TAT). Short TATs help clinicians diagnose and treat patients as quickly as feasible, as well as discharge patients from emergency departments or hospital in-patient services.One of the most common concerns with diagnosis is false and incomplete diagnoses. False-negative readings are the most typical issue with ECG. Other symptoms of any underlying heart didorder, such as chest pain, must be considered, and extra testing may be required. Delayed TAT and incomplete/false diagnosis results can have a negative impact on the market.Modern cardiac imaging, which may include many modalities, is essential to correctly characterize the anatomy and physiology of pediatric and congenital heart disease. Newer imaging modalities, such as cardiac magnetic resonance imaging (CMR) and cardiac computed tomography angiography (CCTA), are increasingly being employed. When it comes to deciding on intervention or surgery for congenital or acquired heart disease, echocardiography and electrocardiography (ECG) are still the gold standards for non-invasive diagnosis. Due to the fast proliferation of medical imaging workstations, companies are working on improving technology and enabling public access to the software.Company growth at workstations for medical imaging will be driven by rising demand for digital platforms, as well as new medical facilities and advancements in the healthcare business. The global electrocardiographs market is predicted to increase as a result of these improvements in multimodal diagnostic imaging for cardiovascular disorders.Impact of COVID-19 on Global Electrocardiographs MarketDue to the increased cardiac complications caused by the COVID-19 virus, the overall market for diagnostic electrocardiographs, particularly conventional electrocardiographs, has a positive impact during this phase, however, implantable loop recorders have a minor impact when compared to conventional cardiac monitors due to the high cost of the equipment. Due to the requisite infrastructure not being in place to deal with the overwhelming number of cases in most nations, the impact was greater, particularly in the first months of February and March.The electrocardiographs (ECG) machine is one of the key instruments for measuring the extent of cardiac involvement in COVID-19 patients and the effect of medications in this scenario due to its wide accessibility, low cost, and ability to be studied remotely.Market SegmentationElectrocardiographs Market (by Product Type)Different technologies that are studied and analyzed under the global electrocardiographs market report include conventional devices and emerging devices.Conventional devices generate the highest revenue in the electrocardiographs market, and emerging devices are expected to rise at a faster pace during the forecast period 2021-2031. This is mostly due to a rise in technologically advanced options and features like portability, constant monitoring, and cloud data sharing.Global Electrocardiographs Market (Conventional Devices)Different product types that are studied and analyzed under conventional devices segment include resting ECG machines and stress ECG machines.In the global electrocardiographs market, resting ECG machines generate the most revenue, while stress ECG machines are projected to expand at the fastest rate during the forecast period 2021-2031. Stress lelectrocardiography offers the advantages of being widely available, having a minimal initial investment, and adding value by allowing assessment of heart structure as well as myocardial response to a potentially ischemic stimulus. All of these elements are projected to propel the market for stress ECG devices ahead.Global Electrocardiographs Market (Emerging Devices)Different product types that are studied and analyzed under emerging devices segment include implantable loop recorders, mobile cardiac telemetry, Holter monitors, and cardiac event monitors.In the electrocardiographs market, implantable loop recorders generate the most revenue, while mobile cardiac telemetry is projected to expand at the fastest rate during the forecast period 2021-2031. Mobile cardiac telemetry provides the convenience of a compact and portable device as well as the ability to detect arrhythmia circumstances that other devices ignore due to its increased capacity to examine the morphology of the electrocardiographs. The key companies are benefited from these advantages over competing ECG devices.Global Electrocardiographs Market (by Region)The different regions covered under the electrocardiographs market report include North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa.North America dominated the global electrocardiographs market in 2020 and is anticipated to uphold its dominance throughout the forecast period. The growth in the market is majorly driven by the increasing adoption of electrocardiographs after several cases of retained “foreign bodies” were reported across the globe. It is mandatory in several countries to implement electrocardiographs for patient’s safety during an operative procedure. Also, the ongoing trend for digital transformation is putting a significant impact on the market growth.Key Market Players and Competition SynopsisSome of the key players operating in the market include Abbott Laboratories, Biotricity, Inc., BIOTRONIK SE & Co. KG, Boston Scientific Corporation, CardioComm Solutions, Inc., Cardioline SpA, Fukuda Denshi Co., Ltd., General Electric Company, Hill-Rom Holdings, Inc., iRhythm Technologies, Inc., Koninklijke Philips N.V., Medtronic plc, Nihon Kohden Corporation, OSI Systems, Inc., and Zoll Medical Corporation (Asahi Kasei Corporation).The electrocardiographs market has witnessed several strategic and technological developments in the past few years, (January 2016- June 2021) undertaken by the different market players to attain their respective market shares in this emerging domain. Some of the strategies covered in this segment are product offerings and upgradation, collaborative activities (partnerships, alliances, and business expansions), mergers and acquisitions, and regulatory and legal activities. The preferred strategy for companies has been collaborative activities.Key Highlights• According to global electrocardiographs market report, conventional devices segmentis dominating the market in 2020 when compared to emerging devices segment under the segmentation – by product type. Emerging devices are forecasted to uphold this position in the market and dominate by the end of the forecast period 2021-2031.• In conventional devices segmentation, resting ECG machines are the market leader. During the forecast period 2021-2031, resting ECG is projected to lead the market. Stress ECG is projected to rise at a faster pace than resting ECG machines, with a CAGR of 6.1%.• In emerging devices segmentation, resting implantable loop recorders is the market leader. By the end of the forecast period 2021-2031, mobile cardiac telemetry is projected to lead the market. Mobile cardiac telemetry is projected to rise at a faster pace than implantable loop recorders, with a CAGR of 11.7%.• When the overall market contribution is considered, conventional devices segment accounts for 57.6% of the total market. • The market holds the highest numbers in the North America region, followed by Asia-Pacific. The U.S. leads the table by contributing 33.2% of the total market in 2020. It is expected that by the end of the forecast period 2021-2031, the Asia-Pacific region will lead the market in the region-based segmentation.
Countries Covered :
North America U.S. CanadaEurope Germany Italy Spain France U.K. Russia Nordic Countries Benelux Countries Rest-of-EuropeAsia-Pacific China Australia and New Zealand Japan India South Korea Rest-of-Asia-PacificLatin America Brazil Mexico Argentina Colombia Rest-of-Latin AmericaMiddle East and Africa K.S.A South Africa U.A.E Rest-of-Middle East and Africa
Keywords :
Electrocardiographs Market, Electrocardiographs Industry, Electrocardiographs Report, Electrocardiographs Market Forecasts, Electrocardiographs Market Trends, Electrocardiographs Market Companies, Electrocardiographs Market Analysis, Electrocardiographs Industry Analysis, What is Electrocardiograph, Electrocardiograph Definition, Electrocardiographs Market Competitive Landscape, Electrocardiographs Market Drivers, Electrocardiographs Market Segments, Electrocardiographs Market Outlook, Electrocardiographs Market Opportunity, Electrocardiographs Market Growth, Electrocardiographs Market Share, Electrocardiographs Market Size, Electrocardiographs Market by product, Electrocardiographs Market by End User, Electrocardiographs Market by Region, Conventional Devices Electrocardiographs Market, Resting ECG Devices Electrocardiographs Market, Stress ECG Devices Electrocardiographs Market, Emerging Devices Electrocardiographs Market, Implantable Loop Recorders Electrocardiographs Market, Mobile Cardiac Telemetry Electrocardiographs Market, Lead-Based Mobile Cardiac Telemetry Electrocardiographs Market, Patch-Based Mobile Cardiac Telemetry Electrocardiographs Market, Holter Monitors Electrocardiographs Market, Cardiac Event Monitors Electrocardiographs Market, Hospitals and Clinics Electrocardiographs Market, Home Care Settings Electrocardiographs Market, Ambulatory Surgical Centers Electrocardiographs Market, North America Electrocardiographs Market, Europe Electrocardiographs Market, Asia-Pacific Electrocardiographs Market, Latin America Electrocardiographs Market, Middle East and Africa Electrocardiographs Market
Press Release :
The global electrocardiographs market is projected to reach $9,826.8 Million by 2031, reveals the premium market intelligence study by BIS Research. The study also highlights that the market is set to witness a CAGR of 7.8% between 2021 and 2031.BIS Research study indicates that the global electrocardiographs market has witnessed significant growth in the past few decades, owing to rising prevalence of cardiovascular diseases, awareness about a better lifestyle, and adoption of advanced technologies in the healthcare sector. In addition, advances in electrocardiographs such as portability, constant monitoring without hindering the daily activities, and sharing data via cloud sharing directly to physicians have stimulated the growth of the electrocardiographs market. The “implantable loop recorder” has gained a lot of popularity recently and proved to be a boon for the cardiology domain. These prominent advancements in technology are expected to drive the global electrocardiographs market forward in the coming years.To emphasize the impact of the COVID-19 pandemic on the global electrocardiographs market, Abdul Wahid, AVP, BIS Research, states, "The COVID-19 pandemic has positively impacted the market. Due to the impact of the novel COVID-19 virus on the cardiac and respiratory system, both emerging and developed countries have witnessed accelerated growth in the adoption of electrocardiographs. The rise in surgical and operative procedures globally and the growing cases of various cardiovascular and related diseases are expected to leave a positive impact on the global electrocardiographs market. The electrocardiographs market has been witnessing increasing activity and innovation from new market entrants. Most of the new features in connected devices are portability of the ECG machines, constant monitoring for days without hindering the daily activities of the patient’s life and sharing of data via cloud sharing directly to a physician. In terms of business model, facilities, product functionality, and user interface, the increased level of competition is expected to pave the way for further innovation.”Key companies operating in the marketLeading companies, market participants, and vendors operating in the market include Abbott Laboratories, Biotricity, Inc., BIOTRONIK SE & Co. KG, Boston Scientific Corporation, CardioComm Solutions, Inc., Cardioline SpA, Fukuda Denshi Co., Ltd., General Electric Company, Hill-Rom Holdings, Inc., iRhythm Technologies, Inc., Koninklijke Philips N.V., Medtronic plc, Nihon Kohden Corporation, OSI Systems, Inc., and Zoll Medical Corporation (Asahi Kasei Corporation).Who should buy this report?• Electrocardiographs manufacturers (emerging and established) to gain a holistic view of the market potential of various devices and software and the developing economies for business expansions.• Established technology companies to gain insights about the market potential, market entry strategies, new technologies in the market, and key competitors.• Cath lab and medical instruments manufacturers to diversify their product portfolio.How can market intelligence on electrocardiographs market add value to an organization’s decision-making process?• Aid in product development• Aid in understanding the regulatory scenario of the market in different regions• Aid in understanding the competitive landscape of the market• Aid in understanding the COVID-19 impact on the global electrocardiographs market• Help in targeting a segment for launching a new product• Aid in understanding the market potential of different technologies• Aid in understanding the end-user requirement• Support in analyzing the market opportunities• Insights about key companies in the marketScope of the Global Electrocardiographs Market Report:• Global trends • COVID-19 impact analysis • Available products, end-user segments, and respective sub-divisions influencing the market • Study of more than 400 products present in the market• Detailed competitive landscape• Technology development scenario• Detailed market share analysis• Study data of over 22 countries• Future perspective of the market• Growth factors• Market challenges/restraints• Detailed market segmentationConsumer demand for mobile and portable cardiac monitors has been growing in recent years, owing to developments in emerging devices such as implantable loop recorders, mobile cardiac telemetry, Holter monitors, and cardiac event monitors. According to the market intelligence report on the global electrocardiographs market, in both developed and emerging economies, devices such as implantable loop recorders and mobile cardiac telemetry have seen increased adoption.Also, some of the key technologies that are expected to have a strong impact on the transformation of the global electrocardiographs market during 2021-2031 include remote ECG monitoring systems and integration of electrocardiograph machines with artificial intelligence (AI).Market Segmentation• Products available under Global Electrocardiographs Market: By product type the market is segmented into conventional devices and emerging devices. Under the conventional devices segment, resting ECG machines and stress ECG machines are included, whereas, under the emerging devices segment, implantable loop recorders, mobile cardiac telemetry, Holter monitors, and cardiac event monitors are included. The stress ECG machines, and the mobile cardiac telemetry segments are expected to grow at the highest CAGR during the forecast period 2021-2031. Revenue generated by the resting ECG and implantable loop recorders segment accounted for approximately 61.5% and 38.0%, respectively, of the overall market revenue in 2020.• End Users of Global Electrocardiographs Market: Hospitals and clinics, home care settings and ambulatory surgical centers, and others are the end users for the global electrocardiographs market.• Regions covered in the Global Electrocardiographs Market: North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. Revenue generated by the U.S. accounted for 33.2% of the overall market revenue in 2020, which was the largest market share in terms of revenue compared to other regions for 2020. The Asia-Pacific is expected to lead the position by the end of the forecast period 2021-2031. The North America region was followed by Asia-Pacific, Europe, Latin America, and the Middle East and Africa.Insightful Questions Covered to Enable Companies take Strategic Decisions:• What was the impact of the COVID-19 pandemic on the global electrocardiographs market?• What are the key technological trends that influence the global electrocardiographs market? What is their future potential?• Who are the emerging or regional players in the global electrocardiographs market?• What are the legal regulations for electrocardiograph devices across various economies?• How has the patent filing trend influenced the growth of the global electrocardiographs market?• Who are the key players in the global electrocardiographs market?• What are the key synergistic activities employed by the companies operating or entering the global electrocardiographs market?• What are the key drivers and restraints for the global electrocardiographs market? • What are the growth opportunities in the global electrocardiographs market? • Which product type is anticipated to grow with the highest CAGR during the forecast period 2021-2031? • Which geographical region is anticipated to dominate the global electrocardiographs market during the forecast period 2021-2031?
Companies Mentioned :
Abbott LaboratoriesBiotricity, Inc.BIOTRONIK SE & Co. KGBoston Scientific CorporationCardioComm Solutions, Inc.Cardioline SpAFukuda Denshi Co., Ltd.General Electric CompanyHill-Rom Holdings, Inc.iRhythm Technologies, Inc.Koninklijke Philips N.V.Medtronic plcNihon Kohden CorporationOSI Systems, Inc.Zoll Medical Corporation (Asahi Kasei Corporation)
Press Release :
The global electrocardiographs market is projected to reach $9,826.8 Million by 2031, reveals the premium market intelligence study by BIS Research. The study also highlights that the market is set to witness a CAGR of 7.8% between 2021 and 2031.BIS Research study indicates that the global electrocardiographs market has witnessed significant growth in the past few decades, owing to rising prevalence of cardiovascular diseases, awareness about a better lifestyle, and adoption of advanced technologies in the healthcare sector. In addition, advances in electrocardiographs such as portability, constant monitoring without hindering the daily activities, and sharing data via cloud sharing directly to physicians have stimulated the growth of the electrocardiographs market. The “implantable loop recorder” has gained a lot of popularity recently and proved to be a boon for the cardiology domain. These prominent advancements in technology are expected to drive the global electrocardiographs market forward in the coming years.To emphasize the impact of the COVID-19 pandemic on the global electrocardiographs market, Abdul Wahid, AVP, BIS Research, states, "The COVID-19 pandemic has positively impacted the market. Due to the impact of the novel COVID-19 virus on the cardiac and respiratory system, both emerging and developed countries have witnessed accelerated growth in the adoption of electrocardiographs. The rise in surgical and operative procedures globally and the growing cases of various cardiovascular and related diseases are expected to leave a positive impact on the global electrocardiographs market. The electrocardiographs market has been witnessing increasing activity and innovation from new market entrants. Most of the new features in connected devices are portability of the ECG machines, constant monitoring for days without hindering the daily activities of the patient’s life and sharing of data via cloud sharing directly to a physician. In terms of business model, facilities, product functionality, and user interface, the increased level of competition is expected to pave the way for further innovation.”Key companies operating in the marketLeading companies, market participants, and vendors operating in the market include Abbott Laboratories, Biotricity, Inc., BIOTRONIK SE & Co. KG, Boston Scientific Corporation, CardioComm Solutions, Inc., Cardioline SpA, Fukuda Denshi Co., Ltd., General Electric Company, Hill-Rom Holdings, Inc., iRhythm Technologies, Inc., Koninklijke Philips N.V., Medtronic plc, Nihon Kohden Corporation, OSI Systems, Inc., and Zoll Medical Corporation (Asahi Kasei Corporation).Who should buy this report?• Electrocardiographs manufacturers (emerging and established) to gain a holistic view of the market potential of various devices and software and the developing economies for business expansions.• Established technology companies to gain insights about the market potential, market entry strategies, new technologies in the market, and key competitors.• Cath lab and medical instruments manufacturers to diversify their product portfolio.How can market intelligence on electrocardiographs market add value to an organization’s decision-making process?• Aid in product development• Aid in understanding the regulatory scenario of the market in different regions• Aid in understanding the competitive landscape of the market• Aid in understanding the COVID-19 impact on the global electrocardiographs market• Help in targeting a segment for launching a new product• Aid in understanding the market potential of different technologies• Aid in understanding the end-user requirement• Support in analyzing the market opportunities• Insights about key companies in the marketScope of the Global Electrocardiographs Market Report:• Global trends • COVID-19 impact analysis • Available products, end-user segments, and respective sub-divisions influencing the market • Study of more than 400 products present in the market• Detailed competitive landscape• Technology development scenario• Detailed market share analysis• Study data of over 22 countries• Future perspective of the market• Growth factors• Market challenges/restraints• Detailed market segmentationConsumer demand for mobile and portable cardiac monitors has been growing in recent years, owing to developments in emerging devices such as implantable loop recorders, mobile cardiac telemetry, Holter monitors, and cardiac event monitors. According to the market intelligence report on the global electrocardiographs market, in both developed and emerging economies, devices such as implantable loop recorders and mobile cardiac telemetry have seen increased adoption.Also, some of the key technologies that are expected to have a strong impact on the transformation of the global electrocardiographs market during 2021-2031 include remote ECG monitoring systems and integration of electrocardiograph machines with artificial intelligence (AI).Market Segmentation• Products available under Global Electrocardiographs Market: By product type the market is segmented into conventional devices and emerging devices. Under the conventional devices segment, resting ECG machines and stress ECG machines are included, whereas, under the emerging devices segment, implantable loop recorders, mobile cardiac telemetry, Holter monitors, and cardiac event monitors are included. The stress ECG machines, and the mobile cardiac telemetry segments are expected to grow at the highest CAGR during the forecast period 2021-2031. Revenue generated by the resting ECG and implantable loop recorders segment accounted for approximately 61.5% and 38.0%, respectively, of the overall market revenue in 2020.• End Users of Global Electrocardiographs Market: Hospitals and clinics, home care settings and ambulatory surgical centers, and others are the end users for the global electrocardiographs market.• Regions covered in the Global Electrocardiographs Market: North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. Revenue generated by the U.S. accounted for 33.2% of the overall market revenue in 2020, which was the largest market share in terms of revenue compared to other regions for 2020. The Asia-Pacific is expected to lead the position by the end of the forecast period 2021-2031. The North America region was followed by Asia-Pacific, Europe, Latin America, and the Middle East and Africa.Insightful Questions Covered to Enable Companies take Strategic Decisions:• What was the impact of the COVID-19 pandemic on the global electrocardiographs market?• What are the key technological trends that influence the global electrocardiographs market? What is their future potential?• Who are the emerging or regional players in the global electrocardiographs market?• What are the legal regulations for electrocardiograph devices across various economies?• How has the patent filing trend influenced the growth of the global electrocardiographs market?• Who are the key players in the global electrocardiographs market?• What are the key synergistic activities employed by the companies operating or entering the global electrocardiographs market?• What are the key drivers and restraints for the global electrocardiographs market? • What are the growth opportunities in the global electrocardiographs market? • Which product type is anticipated to grow with the highest CAGR during the forecast period 2021-2031? • Which geographical region is anticipated to dominate the global electrocardiographs market during the forecast period 2021-2031?
Headline :
Global Electrocardiographs Market to Reach $9,826.8 Million by 2031
Table of Contents :
1 Scope of Research Study1.1 Inclusion and Exclusion Criteria1.2 Key Questions Answered in the Report2 Research Methodology2.1 Data Collection and Analysis2.2 Data Sources2.2.1 Primary Data Sources2.2.2 Secondary Data Sources2.3 Data Sources and Categorization2.4 Data Triangulation2.5 Estimation and Forecasting Methodology2.6 Forecast Period Selection Criteria3 Industry Outlook3.1 Regulatory Scenario3.1.1 North America3.1.1.1 U.S.3.1.1.2 Canada3.1.2 European Union3.1.3 Asia-Pacific3.1.3.1 China3.1.3.2 Japan3.1.4 Latin America3.1.4.1 Brazil3.1.4.2 Mexico3.2 Impact of COVID-19 Pandemic on the Market3.3 Awaited Technological Advancements3.3.1 Remote ECG Monitoring Systems3.3.2 Wearable ECG Technologies3.3.3 Artificial Intelligence-Enabled Electrocardiographs3.4 Patent Landscape3.5 Value Chain Analysis3.6 Architecture of Electrocardiographs System3.7 Epidemiology Assessment3.7.1 Cardiovascular Disorders3.7.2 Atrial Fibrillation4 Competitive Assessment4.1 Market Share Analysis4.1.1 Global Electrocardiographs Market (by Company)4.1.2 Global Conventional Devices Market (by Company)4.1.3 Global Implantable Loop Recorders Market (by Company)4.1.4 Global Mobile Cardiac Telemetry Market (by Company)4.1.5 Global Holter Monitors Market (by Company)4.2 Product Benchmarking4.3 Market Attractiveness Analysis4.3.1 Product Type4.3.2 End User4.3.3 Region4.4 Key Developments and Strategies (Deal Tracking)4.4.1 Collaborative Activities4.4.2 Regulatory Activities4.4.3 Merger and Acquisition Activities4.4.4 New Product Offerings5 Market Dynamics5.1 Impact Analysis5.2 Market Drivers5.2.1 Increasing Prevalence of Cardiovascular Diseases (CVDs) and other Heart-Related Diseases5.2.2 Growing Demands for Point-of-Care Diagnostic Systems5.2.3 Rising End-User Preference for Non-Invasive Diagnostic Technologies over Invasive Technologies5.3 Market Restraints5.3.1 Longer Turnaround Time (TAT)5.3.2 Incomplete and False Diagnosis5.4 Market Trends5.4.1 Rise in Demand for Holter Monitors5.4.2 Development of Insertable Cardiac Monitors5.5 Market Opportunities5.5.1 Growing Market Preference for Multimodal Diagnostic Imaging Systems5.5.2 Implementation of ECG in Hybrid Operating Rooms6 Global Electrocardiographs Market6.1 Global Market Outlook6.2 Key Findings6.3 Assumptions and Limitations7 Global Electrocardiographs Market (by Product Type)7.1 Overview7.2 Market Size and Forecast7.2.1 Conventional Devices7.2.1.1 Resting ECG Devices7.2.1.2 Stress ECG Devices7.2.2 Emerging Devices7.2.2.1 Implantable Loop Recorders7.2.2.2 Mobile Cardiac Telemetry7.2.2.2.1.1 Lead-Based Mobile Cardiac Telemetry7.2.2.2.2 Patch-Based Mobile Cardiac Telemetry7.2.2.3 Holter Monitors7.2.2.4 Cardiac Event Monitors8 Global Electrocardiographs Market (by End User)8.1 Overview8.1.1 Market Size and Forecast8.1.1.1 Hospitals and Clinics8.1.1.2 Home Care Settings and Ambulatory Surgical Centers8.1.1.3 Others9 Global Electrocardiographs Market (by Region)9.1 Overview9.2 North America9.2.1 Key Findings9.2.2 Market Size and Forecast9.2.2.1 Product Type9.2.2.2 End User9.2.2.3 Country9.2.2.3.1 U.S.9.2.2.3.2 Canada9.3 Europe9.3.1 Key Findings9.3.2 Market Size and Forecast9.3.2.1 Product Type9.3.2.2 End User9.3.2.3 Country9.3.2.3.1 Germany9.3.2.3.2 U.K.9.3.2.3.3 France9.3.2.3.4 Italy9.3.2.3.5 Spain9.3.2.3.6 Russia9.3.2.3.7 Nordic Countries9.3.2.3.8 Benelux Countries9.3.2.3.9 Rest-of-Europe9.4 Asia-Pacific9.4.1 Key Findings9.4.2 Market Size and Forecast9.4.2.1 Product Type9.4.2.2 End User9.4.2.3 Country9.4.2.3.1 China9.4.2.3.2 Japan9.4.2.3.3 South Korea9.4.2.3.4 India9.4.2.3.5 Australia and New Zealand9.4.2.3.6 Rest-of-Asia-Pacific9.5 Latin America9.5.1 Key Findings9.5.2 Market Size and Forecast9.5.2.1 Product Type9.5.2.2 End User9.5.2.3 Country9.5.2.3.1 Brazil9.5.2.3.2 Mexico9.5.2.3.3 Argentina9.5.2.3.4 Colombia9.5.2.3.5 Rest-of-Latin America9.6 Middle East and Africa9.6.1 Key Findings9.6.2 Market Size and Forecast9.6.2.1 Product Type9.6.2.2 End User9.6.2.3 Country9.6.2.3.1 K.S.A9.6.2.3.2 South Africa9.6.2.3.3 U.A.E9.6.2.3.4 Rest-of-Middle East and Africa10 Company Profiles10.1 Overview10.2 Abbott Laboratories10.2.1 Company Outlook10.2.2 Company Description10.2.3 Financials10.2.4 SWOT Analysis10.3 Biotricity, Inc.10.3.1 Company Outlook10.3.2 Company Description10.3.3 Financials10.3.4 SWOT Analysis10.4 BIOTRONIK SE & Co. KG10.4.1 Company Overview10.4.2 Company Description10.4.3 SWOT Analysis10.5 Boston Scientific Corporation10.5.1 Company Outlook10.5.2 Company Description10.5.3 Financials10.5.4 SWOT Analysis10.6 CardioComm Solutions, Inc.10.6.1 Company Outlook10.6.2 Company Description10.6.3 Financials10.6.4 SWOT Analysis10.7 Cardioline SpA10.7.1 Company Overview10.7.2 Company Description10.7.3 SWOT Analysis10.8 Fukuda Denshi Co., Ltd.10.8.1 Company Outlook10.8.2 Company Description10.8.3 Financials10.8.4 SWOT Analysis10.9 General Electric Company10.9.1 Company Outlook10.9.2 Company Description10.9.3 Financials10.9.4 SWOT Analysis10.1 Hill-Rom Holdings, Inc.10.10.1 Company Outlook10.10.2 Company Description10.10.3 Financials10.10.4 SWOT Analysis10.11 iRhythm Technologies, Inc.10.11.1 Company Outlook10.11.2 Company Description10.11.3 Financials10.11.4 SWOT Analysis10.12 Koninklijke Philips N.V.10.12.1 Company Outlook10.12.2 Company Description10.12.3 Financials10.12.4 SWOT Analysis10.13 Medtronic plc10.13.1 Company Outlook10.13.2 Company Description10.13.3 Financials10.13.4 SWOT Analysis10.14 Nihon Kohden Corporation10.14.1 Company Outlook10.14.2 Company Description10.14.3 Financials10.14.4 SWOT Analysis10.15 OSI Systems, Inc.10.15.1 Company Outlook10.15.2 Company Description10.15.3 Financials10.15.4 SWOT Analysis10.16 Zoll Medical Corporation (Asahi Kasei Corporation)10.16.1 Company Outlook10.16.2 Company Description10.16.3 Financials10.16.4 SWOT AnalysisList of Tables Table 3.1: Medical Device Classification and Pre-Marketing Procedures in JapanTable 3.2: Patent Landscape (by Country), January 2017-July 2021Table 4.1: Product Benchmarking Analysis of Key PlayersTable 5.1: Impact Analysis: Market DriversTable 5.2: Impact Analysis: Market RestraintsTable 9.1: Prevalence of CVDs in North America Region (2000, 2010, 2018, and 2019)Table 9.2: North America Electrocardiographs Market (by Product Type), $Million, 2020-2031Table 9.3: Prevalence of CVDs in Europe Region (2000, 2010, 2018, and 2019)Table 9.4: Europe Electrocardiographs Market (by Product Type), $Million, 2020-2031Table 9.5: Prevalence of CVDs in Asia-Pacific Region (2000, 2010, 2018, and 2019)Table 9.6: Asia-Pacific Electrocardiographs Market (by Product Type), $Million, 2020-2031Table 9.7: Prevalence of CVDs in Latin America Region (2000, 2010, 2018, and 2019)Table 9.8: Latin America Electrocardiographs Market (by Product Type), $Million, 2020-2031Table 9.9: Prevalence of CVDs in Middle East and Africa Region (2000, 2010, 2018, and 2019)Table 9.10: Middle East and Africa Electrocardiographs Market (by Product Type), $Million, 2020-2031Table 10.1: Abbott Laboratories: R&D Investments, $Million, 2018-2020Table 10.2: Biotricity, Inc.: R&D Investments, $Million, 2018-2020Table 10.3: Boston Scientific Corporation: R&D Investments, $Million, 2018-2020Table 10.4: CardioComm Solutions, Inc.: R&D Investments, $Million, 2018-2020Table 10.5: General Electric Company: R&D Investments, $Million, 2018-2020Table 10.6: Hill-Rom Holdings, Inc.: R&D Investments, $Million, 2018-2020Table 10.7: iRhythm Technologies, Inc.: R&D Investments, $Million, 2018-2020Table 10.8: Koninklijke Philips N.V.: R&D Investments, $Million, 2018-2020Table 10.9: Medtronic plc: R&D Investments, $Million, 2019-2021Table 10.10: Nihon Kohden Corporation: R&D Investments, $Million, 2019-2021Table 10.11: OSI Systems, Inc.: R&D Investments, $Million, 2018-2020List of Figures Figure 1: Global Electrocardiographs Market, $Million, 2020, 2024, 2027, and 2031Figure 2: Dominating Segments of the Global Electrocardiographs Market, $Million, 2020 and 2031Figure 3: Global Electrocardiographs Market (by Product Type), $Million, 2020, 2027, and 2031Figure 4: Global Electrocardiographs Market (by End User), 2020, 2027, and 2031Figure 5: Global Electrocardiographs Market (by Region), $Million, 2020 and 2031Figure 6: Growth Propelling and Inhibiting FactorsFigure 7: Key Developments and Strategies (by Category), January 2017-July 2021Figure 1.1: Global Electrocardiographs Market SegmentationFigure 1.2: Global Electrocardiographs Market, Regional SegmentationFigure 2.1: Global Electrocardiographs Market: Research MethodologyFigure 2.2: Primary ResearchFigure 2.3: Secondary ResearchFigure 2.4: Data TriangulationFigure 3.1: Regulatory Process for Medical Devices in the U.S.Figure 3.2: Regulatory Process for Medical Devices in CanadaFigure 3.3: MDR Transitional Provisions (EU)Figure 3.4: Regulatory Pathway for Medical Devices in ChinaFigure 3.5: Postulated Cardiovascular Involvement in COVID-19 PandemicFigure 3.6: Value Chain Analysis: Key EntitiesFigure 3.7: Architecture OverviewFigure 3.8: Global Prevalence (Cardiovascular Disorders), $Million, 1990-2019Figure 3.9: Global Prevalence (Atrial Fibrillation), $Million, 1990-2019Figure 4.1: Global Electrocardiographs Market Share Analysis (by Company), 2020Figure 4.2: Global Conventional Devices Market Share Analysis (by Company), 2020Figure 4.3: Global Implantable Loop Recorders Market Share Analysis (by Company), 2020Figure 4.4: Global Mobile Cardiac Telemetry Market Share Analysis (by Company), 2020Figure 4.5: Global Holter Monitors Market Share Analysis (by Company), 2020Figure 4.6: Market Attractiveness Analysis (Product Type), 2020-2031Figure 4.7: Market Attractiveness Analysis (End User), 2020-2031Figure 4.8: Market Attractiveness Analysis (Region), 2020-2031Figure 4.9: Key Developments and Strategies (by Category), January 2017-July 2021Figure 4.10: Key Developments and Strategies (Collaborative Activities), January 2017-July 2021Figure 4.11: Key Developments and Strategies (Regulatory Activities), January 2017- July 2021Figure 4.12: Key Developments and Strategies (Merger and Acquisition Activities), January 2017-July 2021Figure 4.13: Key Developments and Strategies (New Product Offerings), January 2017-July 2021Figure 5.1: Market DynamicsFigure 5.2: Risk Assessment of Non-Invasive TestingFigure 6.1: Global Electrocardiographs Market, $Million, 2020-2031Figure 7.1: Global Electrocardiographs Market Segmentation (by Product Type)Figure 7.2: Opportunity Assessment (by Product Type), $Million, 2020, 2026, and 2031Figure 7.3: Global Electrocardiographs Market (Resting ECG Devices), $Million, 2020-2031Figure 7.4: Modifications of Stress ElectrocardiographsFigure 7.5: Global Electrocardiographs Market (Stress ECG Devices), $Million, 2020-2031Figure 7.6: Global Electrocardiographs Market (Implantable Loop Recorders), $Million, 2020-2031Figure 7.7: Mobile Cardiac Telemetry (MCT) WorkflowFigure 7.8: Global Electrocardiographs Market (Mobile Cardiac Telemetry), $Million, 2020-2031Figure 7.9: Global Electrocardiographs Market (Lead-Based Mobile Cardiac Telemetry), $Million, 2020-2031Figure 7.10: Global Electrocardiographs Market (Patch-Based Mobile Cardiac Telemetry), $Million, 2020-2031Figure 7.11: Holter Monitors WorkflowFigure 7.12: Global Electrocardiographs Market (Holter Monitors), $Million, 2020-2031Figure 7.13: Types of Cardiac Event MonitorsFigure 7.14: Global Electrocardiographs Market (Cardiac Event Monitors), $Million, 2020-2031Figure 8.1: Opportunity Assessment (by End-User), $Million, 2020, 2026, and 2031Figure 8.2: Global Electrocardiographs Market (Hospitals and Clinics), $Million, 2020-2031Figure 8.3: Global Electrocardiographs Market (Home Care Settings and Ambulatory Surgical Centers), $Million, 2020-2031Figure 8.4: Global Electrocardiographs Market (Others), $Million, 2020-2031Figure 9.1: Global Electrocardiographs Market Scenario (by Region), 2020 and 2031Figure 9.2: Opportunity Assessment (by Region), $Million, 2020, 2026, and 2031Figure 9.3: North America Electrocardiographs Market, $Million, 2020-2031Figure 9.4: North America Electrocardiographs Market (by Product Type), $Million, 2020-2031Figure 9.5: North America Electrocardiographs Market (by End User), $Million, 2020-2031Figure 9.6: U.S. Electrocardiographs Market, $Million, 2020-2031Figure 9.7: Canada Electrocardiographs Market, $Million, 2020-2031Figure 9.8: Europe Electrocardiographs Market, $Million, 2020-2031Figure 9.9: Europe Electrocardiographs Market (by Product Type), $Million, 2020-2031Figure 9.10: Europe Electrocardiographs Market (by End User), $Million, 2020-2031Figure 9.11: Germany Electrocardiographs Market, $Million, 2020-2031Figure 9.12: U.K. Electrocardiographs Market, $Million, 2020-2031Figure 9.13: France Electrocardiographs Market, $Million, 2020-2031Figure 9.14: Italy Electrocardiographs Market, $Million, 2020-2031Figure 9.15: Spain Electrocardiographs Market, $Million, 2020-2031Figure 9.16: Russia Electrocardiographs Market, $Million, 2020-2031Figure 9.17: Nordic Countries Electrocardiographs Market, $Million, 2020-2031Figure 9.18: Benelux Countries Electrocardiographs Market, $Million, 2020-2031Figure 9.19: Rest-of-Europe Electrocardiographs Market, $Million, 2020-2031Figure 9.20: Asia-Pacific Electrocardiographs Market, $Million, 2020-2031Figure 9.21: Asia-Pacific Electrocardiographs Market (by Product Type), $Million, 2020-2031Figure 9.22: Asia-Pacific Electrocardiographs Market (by End User), $Million, 2020-2031Figure 9.23: China Electrocardiographs Market, $Million, 2020-2031Figure 9.24: Japan Electrocardiographs Market, $Million, 2020-2031Figure 9.25: South Korea Electrocardiographs Market, $Million, 2020-2031Figure 9.26: India Electrocardiographs Market, $Million, 2020-2031Figure 9.27: Australia and New Zealand Electrocardiographs Market, $Million, 2020-2031Figure 9.28: Rest-of-Asia-Pacific Electrocardiographs Market, $Million, 2020-2031Figure 9.29: Latin America Electrocardiographs Market, $Million, 2020-2031Figure 9.30: Latin America Electrocardiographs Market (by Product Type), $Million, 2020-2031Figure 9.31: Latin America Electrocardiographs Market (by End User), $Million, 2020-2031Figure 9.32: Brazil Electrocardiographs Market, $Million, 2020-2031Figure 9.33: Mexico Electrocardiographs Market, $Million, 2020-2031Figure 9.34: Argentina Electrocardiographs Market, $Million, 2020-2031Figure 9.35: Colombia Electrocardiographs Market, $Million, 2020-2031Figure 9.36: Rest-of-Latin America Electrocardiographs Market, $Million, 2020-2031Figure 9.37: Middle East and Africa Electrocardiographs Market, $Million, 2020-2031Figure 9.38: Middle East and Africa Electrocardiographs Market (by Product Type), $Million, 2020-2031Figure 9.39: Middle East and Africa Electrocardiographs Market (by End User), $Million, 2020-2031Figure 9.40: K.S.A Electrocardiographs Market, $Million, 2020-2031Figure 9.41: South Africa Electrocardiographs Market, $Million, 2020-2031Figure 9.42: U.A.E Electrocardiographs Market, $Million, 2020-2031Figure 9.43: Rest-of-Middle East and Africa Electrocardiographs Market, $Million, 2020-2031Figure 10.1: Abbott Laboratories: Overall Financials, $Million, 2018-2020Figure 10.2: Abbott Laboratories: Net Revenue (by Segment) (Medical Devices), $Million, 2018-2020Figure 10.3: Abbott Laboratories: Net Revenue (by Region) (Medical Devices), $Million, 2018-2020Figure 10.4: Biotricity, Inc.: Overall Financials, $Million, 2018-2020Figure 10.5: Boston Scientific Corporation: Overall Financials, $Million, 2018-2020Figure 10.6: Boston Scientific Corporation: Net Revenue (by Segment), $Million, 2018-2020Figure 10.7: Boston Scientific Corporation: Net Revenue (by Region), $Million, 2018-2020Figure 10.8: CardioComm Solutions, Inc.: Overall Financials, $Million, 2018-2020Figure 10.9: CardioComm Solutions, Inc.: Net Revenue (by Segment), $Million, 2020Figure 10.10: CardioComm Solutions, Inc.: Net Revenue (by Region), $Million, 2018-2020Figure 10.11: Fukuda Denshi Co., Ltd.: Overall Financials, $Million, 2019-2021Figure 10.12: Fukuda Denshi Co., Ltd.: Net Revenue (by Segment), $Million, 2019-2021Figure 10.13: General Electric Company: Overall Financials, $Million, 2018-2020Figure 10.14: General Electric Company: Net Revenue (by Segment) (Healthcare), $Million, 2018-2020Figure 10.15: General Electric Company: Net Revenue (by Region), $Million, 2018-2020Figure 10.16: Hill-Rom Holdings, Inc.: Overall Financials, $Million, 2018-2020Figure 10.17: Hill-Rom Holdings, Inc.: Net Revenue (by Segment), $Million, 2018-2020Figure 10.18: Hill-Rom Holdings, Inc.: Net Revenue (by Region), $Million, 2018-2020Figure 10.19: iRhythm Technologies, Inc.: Overall Financials, $Million, 2018-2020Figure 10.20: Koninklijke Philips N.V.: Overall Financials, $Million, 2018-2020Figure 10.21: Koninklijke Philips N.V.: Net Revenue (by Segment), $Million, 2018-2020Figure 10.22: Koninklijke Philips N.V.: Net Revenue (by Region), $Million, 2018-2020Figure 10.23: Medtronic plc: Overall Financials, $Million, 2019-2021Figure 10.24: Medtronic plc: Net Revenue (by Segment) (Cardiovascular), $Million, 2019-2021Figure 10.25: Medtronic plc: Net Revenue (by Region), $Million, 2019-2021Figure 10.26: Nihon Kohden Corporation: Overall Financials, $Million, 2019-2021Figure 10.27: Nihon Kohden Corporation: Net Revenue (by Segment), $Million, 2019-2021Figure 10.28: Nihon Kohden Corporation: Net Revenue (by Region), $Million, 2019-2021Figure 10.29: OSI Systems, Inc.: Overall Financials, $Million, 2018-2020Figure 10.30: OSI Systems, Inc.: Net Revenue (by Segment), $Million, 2018-2020Figure 10.31: OSI Systems, Inc.: Net Revenue (by Region), $Million, 2018-2020Figure 10.32: Asahi Kasei Corporation: Overall Financials, $Million, 2019-2021Figure 10.33: Asahi Kasei Corporation: Net Revenue (by Segment), $Million, 2019-2021Figure 10.34: Asahi Kasei Corporation: Net Revenue (by Region), $Million, 2019-2021